| 3.27 0.02 (0.62%) | 07-31 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.25 |
1-year : | 4.71 |
| Resists | First : | 3.64 |
Second : | 4.03 |
| Pivot price | 3.37 |
|||
| Supports | First : | 3 | Second : | 2.5 |
| MAs | MA(5) : | 3.25  |
MA(20) : | 3.43 |
| MA(100) : | 4.25 |
MA(250) : | 5.62 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 39.9 |
D(3) : | 39.4 |
| RSI | RSI(14): 37.9 |
|||
| 52-week | High : | 8.5 | Low : | 3 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SIGA ] has closed above bottom band by 34.4%. Bollinger Bands are 14% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.31 - 3.33 | 3.33 - 3.35 |
| Low: | 3.1 - 3.13 | 3.13 - 3.15 |
| Close: | 3.23 - 3.27 | 3.27 - 3.3 |
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Sun, 02 Aug 2026
Arrowstreet Capital Limited Partnership Has $8.16 Million Stock Holdings in Siga Technologies Inc. $SIGA - MarketBeat
Fri, 31 Jul 2026
SIGA Technologies Inc (SIGA) Institutional Confidence - TradingKey
Thu, 30 Jul 2026
SIGA CEO and CFO Join Aug. 6 Business Update Webcast - Stock Titan
Thu, 30 Jul 2026
SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results - Yahoo Finance
Wed, 29 Jul 2026
SIGA|SIGA Technologies Inc|Price:3.330|Chg%:+0.230 - TradingKey
Tue, 28 Jul 2026
Siga Technologies: Q2 Earnings Due, New TPOXX Orders A Must (NASDAQ:SIGA) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 72 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 42.8 (%) |
| Held by Institutions | 49.8 (%) |
| Shares Short | 3,930 (K) |
| Shares Short P.Month | 3,410 (K) |
| EPS | 0.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.1 |
| Profit Margin | 21.5 % |
| Operating Margin | -85.3 % |
| Return on Assets (ttm) | 5.5 % |
| Return on Equity (ttm) | 11 % |
| Qtrly Rev. Growth | -11.4 % |
| Gross Profit (p.s.) | 0.56 |
| Sales Per Share | 1.3 |
| EBITDA (p.s.) | 0.29 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 28 (M) |
| Levered Free Cash Flow | 59 (M) |
| PE Ratio | 11.67 |
| PEG Ratio | 3.3 |
| Price to Book value | 1.54 |
| Price to Sales | 2.5 |
| Price to Cash Flow | 8.45 |
| Dividend | 0.6 |
| Forward Dividend | 0 |
| Dividend Yield | 18.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|